发明名称 |
Incontinence treatment methods |
摘要 |
The invention relates to the fields of pharmaceutical chemistry and pharmacological treatments. More specifically, the invention relates to compositions and methods for the treatment of incontinence, voiding disorders associated with lower urinary tract dysfunctions and/or the urethro-vesical and anal sphincteral disorders. The invention can be used, for example, for the treatment of pollakiuria, urinary urgency, nocturia or enuresis, true faecal incontinence, functional faecal incontinence (FFI), passive faecal incontinence, faecal urgency and/or faecal seepage. The invention is suitable for preventive or curative use with all mammals, particularly humans. |
申请公布号 |
US9511061(B2) |
申请公布日期 |
2016.12.06 |
申请号 |
US200612158444 |
申请日期 |
2006.12.20 |
申请人 |
IXALTIS |
发明人 |
Lluel Philippe;Palea Stefano |
分类号 |
A61K31/445 |
主分类号 |
A61K31/445 |
代理机构 |
Saliwanchik, Lloyd & Eisenschenk |
代理人 |
Saliwanchik, Lloyd & Eisenschenk |
主权项 |
1. A method for treating stress urinary incontinence or mixed incontinence, the method comprising administering to a subject in need thereof an effective amount of 4-[(2-naphthalenyl)-methoxy]-piperidine, or a pharmaceutically acceptable salt thereof, in an amount between 0.001 and 1000 mg/day. |
地址 |
Toulouse FR |